Aardvark Adventures Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Aardvark Adventures

DAVE 201.66

-0.6%

10:28 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ~digs who wrote (1909)	12/16/2005 8:55:26 AM
From: ~digs	Read Replies (2) of 7944

NPTH @ 7.91 img391.imageshack.us Enpath Medical, Inc. engages in the design, development, manufacture, and marketing of percutaneous delivery systems and stimulation leads technologies. The company operates in two divisions, The Enpath Delivery Systems and the Enpath Lead Technologies. The Enpath Delivery Systems division manufactures and markets a family of percutaneous venous vessel introducers that enable physicians to create a conduit, through which they can insert infusion catheters, implantable ports, and pacemaker leads into a blood vessel. It also provides valved introducers, and safety needles. The Enpath Lead Technologies division offers custom designed implantable stimulation leads, adapters, and delivery systems for the cardiac and neuromodulation markets. This division also provides laser processing and contract manufacturing services for medical device customers for implantable and disposable devices. ----------- Message 21977755

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next